This section of the website is for UK patients only.

If you are a UK Healthcare Professional please click here.

If you are a member of the UK public please click here.

*Advanced (unresectable or metastatic)
**Advanced (locally advanced or metastatic)
NSCLC - Non-small cell lung cancer
RCC - renal cell carcinoma

Date of preparation: April 2016

Contact us Legal Notice
Privacy policy Patient information leaflet

Reporting of side effects and additional monitoring

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See www.mhra.gov.uk/yellowcard for how to report side effects. Side effects should also be reported to Bristol-Myers Squibb Medical Information on
0800 731 1736 or medical.information@bms.com.

*Advanced (unresectable or metastatic)
**Advanced (locally advanced or metastatic)
NSCLC - Non-small cell lung cancer
RCC - renal cell carcinoma

Date of preparation: April 2016

The information on this website is intended for patients only.

Please confirm you are a patient in the UK.